1. Home
  2. NEOG vs IMNM Comparison

NEOG vs IMNM Comparison

Compare NEOG & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEOG
  • IMNM
  • Stock Information
  • Founded
  • NEOG 1981
  • IMNM 2006
  • Country
  • NEOG United States
  • IMNM United States
  • Employees
  • NEOG N/A
  • IMNM N/A
  • Industry
  • NEOG Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • IMNM Medicinal Chemicals and Botanical Products
  • Sector
  • NEOG Health Care
  • IMNM Health Care
  • Exchange
  • NEOG Nasdaq
  • IMNM Nasdaq
  • Market Cap
  • NEOG 1.0B
  • IMNM 945.8M
  • IPO Year
  • NEOG 1989
  • IMNM 2020
  • Fundamental
  • Price
  • NEOG $5.74
  • IMNM $9.68
  • Analyst Decision
  • NEOG Buy
  • IMNM Strong Buy
  • Analyst Count
  • NEOG 3
  • IMNM 8
  • Target Price
  • NEOG $7.50
  • IMNM $24.75
  • AVG Volume (30 Days)
  • NEOG 4.6M
  • IMNM 756.6K
  • Earning Date
  • NEOG 10-09-2025
  • IMNM 08-06-2025
  • Dividend Yield
  • NEOG N/A
  • IMNM N/A
  • EPS Growth
  • NEOG N/A
  • IMNM N/A
  • EPS
  • NEOG N/A
  • IMNM N/A
  • Revenue
  • NEOG $894,661,000.00
  • IMNM $12,589,000.00
  • Revenue This Year
  • NEOG N/A
  • IMNM N/A
  • Revenue Next Year
  • NEOG $1.86
  • IMNM $154.73
  • P/E Ratio
  • NEOG N/A
  • IMNM N/A
  • Revenue Growth
  • NEOG N/A
  • IMNM 16.74
  • 52 Week Low
  • NEOG $3.87
  • IMNM $5.15
  • 52 Week High
  • NEOG $17.96
  • IMNM $16.73
  • Technical
  • Relative Strength Index (RSI)
  • NEOG 59.33
  • IMNM 48.64
  • Support Level
  • NEOG $5.52
  • IMNM $8.67
  • Resistance Level
  • NEOG $5.92
  • IMNM $10.65
  • Average True Range (ATR)
  • NEOG 0.22
  • IMNM 0.67
  • MACD
  • NEOG -0.02
  • IMNM -0.07
  • Stochastic Oscillator
  • NEOG 66.67
  • IMNM 49.27

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: